FDA Inspection 1258173 — The University Of Texas MD Anderson Cancer Center IRB

The University Of Texas MD Anderson Cancer Center IRB — FEI 1626261

The FDA completed an inspection of The University Of Texas MD Anderson Cancer Center IRB on Dec 12, 2024 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 12, 2024
Fiscal Year
2025
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

IRB